CD8A and squamous cell carcinoma: Another potential study limitation may be that immunological analysis was performed on day five after treatment initiation even though the levels of cytotoxic CD8+ T-cells may peak at a later time point as the one previously found for AFL treatment in a model of squamous cell carcinomas [28].